Iran Press/ Europe: Kazem Jalali also said an ACTOVER pharmaceutical company had the necessary standards to produce Sputnik-V.
Kazem Jalali noted that the vaccine is 98 percent effective against COVID-19.
He said that the 60 million dose contract had been signed between Iran and Russia.
Jalali stressed that the Sputnik-V vaccine is well received in Iran, though there are limitations in the world.
Referring to Iran's efforts to combat COVID-19, he expressed hope that the process of receiving vaccines from Russia would be accelerated.
207/216
Read more:
Iran receives new shipment of Russian Sputnik corona vaccine
Iran, Russia discuss ways of bilateral cooperation
